Barriers and Facilitators of Persistence With Adjuvant Osimertinib

Clinical trial NCT07542210 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07542210
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2026-06-01
Primary completion: 2026-08-15
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.